Equities

Ibere Pharmaceuticals

Ibere Pharmaceuticals

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)9.85
  • Today's Change0.00 / 0.00%
  • Shares traded505.00
  • 1 Year change+1.76%
  • Beta--
Data delayed at least 15 minutes, as of Aug 09 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.

  • Revenue in USD (TTM)0.00
  • Net income in USD5.54m
  • Incorporated2020
  • Employees--
  • Location
    Ibere Pharmaceuticals2005 Market Street, Suite 2030PHILADELPHIA 19103United StatesUSA
  • Phone+1 (267) 765-3222
  • Websitehttps://www.iberepharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Deep Medicine Acquisition Corp0.00-414.04k165.98m----1.34-----0.0253-0.02530.007.55---------------------------99.010.00-------597.05------
Special Opportunities Fund Inc.-100.00bn-100.00bn167.18m--------------------------------------------------------------
Voya Infrstrcture Industrls and Mtrls Fd-100.00bn-100.00bn168.55m--------------------------------------------------------------
AG Mortgage Investment Trust Inc117.14m-34.83m169.44m0.00--0.6559--1.45-0.8226-0.82265.6721.280.0387--2.12---0.4265-1.02-0.656-3.6341.5046.95-11.01-27.25--1.110.8756---5.18-10.49119.9011.33---28.70
Ibere Pharmaceuticals0.005.54m169.91m--30.671.3030.67--0.32120.32120.007.580.00------3.99--4.00--------------0.00------27,213.71------
Grayscale Ethereum Classic Trust (Etc)0.00401.30m170.02m--0.42370.2985----28.6828.680.0040.70----------------------------0.00------4,900.69------
abrdn Standard Globl Infrstrctr Incm Fnd18.07m22.41m170.72m--7.620.8322--9.452.532.532.0423.170.0903------11.20--11.22--81.94--124.00------0.00--1,859.32--821.36------
Western Asset Global High Income Fnd Inc-100.00bn-100.00bn171.82m0.00------------------------------------------------------------
JATT Acquisition Corp0.007.03m172.50m--24.541.3229.07--0.40750.40750.007.560.00------10.02--10.05--------------0.00--------------
AP Acquisition Corp-100.00bn-100.00bn172.68m----1.26----------8.00----------------------------0.0002--------------
Nuveen Intermediate Duration Qlty Mun FD8.29m8.51m173.17m--20.340.8874--20.890.650.650.632914.900.0331--1.50--3.403.043.423.0976.1571.31102.7188.57----0.219876.975.59-1.40145.00-2.13---4.53
Murphy Canyon Acquisition Corp-100.00bn-100.00bn173.20m--------------------------------------------------------------
Clough Global Equity Fund-100.00bn-100.00bn173.72m--------------------------------------------------------------
BNY Mellon High Yield Strategies Fund-100.00bn-100.00bn173.84m0.00------------------------------------------------------------
Lightjump Acquisition Corp0.00-921.79k174.57m----1.29-----0.0531-0.05310.007.780.00-------0.6645---0.671--------------0.0056-------579.78------
Data as of Aug 09 2022. Currency figures normalised to Ibere Pharmaceuticals's reporting currency: US Dollar USD

Institutional shareholders

52.86%Per cent of shares held by top holders
HolderShares% Held
Brown Advisory LLCas of 30 Jun 20222.73m19.77%
Citadel Advisors LLCas of 31 Mar 2022777.70k5.64%
Hudson Bay Capital Management LPas of 31 Mar 2022617.00k4.47%
Marshall Wace LLPas of 31 Mar 2022532.19k3.86%
Polar Asset Management Partners, Inc.as of 31 Mar 2022500.00k3.62%
Linden Advisors LPas of 31 Mar 2022450.00k3.26%
Millennium Management LLCas of 31 Mar 2022441.88k3.20%
Sculptor Capital LPas of 31 Mar 2022425.00k3.08%
Omni Partners LLPas of 31 Mar 2022422.03k3.06%
Koch Industries, Inc. (Investment Management)as of 31 Mar 2022400.00k2.90%
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.